These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10456803)

  • 1. Dopamine systems in human immunodeficiency virus-associated dementia.
    Lopez OL; Smith G; Meltzer CC; Becker JT
    Neuropsychiatry Neuropsychol Behav Neurol; 1999 Jul; 12(3):184-92. PubMed ID: 10456803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Depression and frontal dysfunction: risks for the elderly?].
    Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
    Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation.
    Rajput AH; Sitte HH; Rajput A; Fenton ME; Pifl C; Hornykiewicz O
    Neurology; 2008 Apr; 70(16 Pt 2):1403-10. PubMed ID: 18172064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers.
    Kish SJ; Chang LJ; Mirchandani L; Shannak K; Hornykiewicz O
    Ann Neurol; 1985 Nov; 18(5):530-6. PubMed ID: 2416269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra.
    Nosheny RL; Bachis A; Aden SA; De Bernardi MA; Mocchetti I
    J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dementia and neurocognitive disorders due to HIV-1 infection.
    Ances BM; Ellis RJ
    Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
    Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
    Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS dementia-related psychosis: is there a window of vulnerability?
    el-Mallakh RS
    AIDS Care; 1992; 4(4):381-7. PubMed ID: 1493145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontal-subcortical dementias.
    Bonelli RM; Cummings JL
    Neurologist; 2008 Mar; 14(2):100-7. PubMed ID: 18332839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV dementia: the role of the basal ganglia and dopaminergic systems.
    Berger JR; Arendt G
    J Psychopharmacol; 2000; 14(3):214-21. PubMed ID: 11106299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial dopamine loss enhances activated caspase-3 activity: differential outcomes in striatal projection systems.
    Ariano MA; Grissell AE; Littlejohn FC; Buchanan TM; Elsworth JD; Collier TJ; Steece-Collier K
    J Neurosci Res; 2005 Nov; 82(3):387-96. PubMed ID: 16180225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 associated dementia: symptoms and causes.
    Ghafouri M; Amini S; Khalili K; Sawaya BE
    Retrovirology; 2006 May; 3():28. PubMed ID: 16712719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
    Theodore S; Cass WA; Maragos WF
    Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism.
    Oueslati A; Breysse N; Amalric M; Kerkerian-Le Goff L; Salin P
    Eur J Neurosci; 2005 Dec; 22(11):2765-74. PubMed ID: 16324110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic neurons intrinsic to the striatum.
    Huot P; Parent A
    J Neurochem; 2007 Jun; 101(6):1441-7. PubMed ID: 17286588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disturbances in higher function in Parkinson's disease.
    Tamaru F
    Eur Neurol; 1997; 38 Suppl 2():33-6. PubMed ID: 9387801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The human immunodeficiency virus type 1 and the developing central nervous system].
    Henao JA; Vanegas N; Cano OD; Hiromi JC; Rugeles MT
    Biomedica; 2005 Mar; 25(1):136-47. PubMed ID: 15962910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.